These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

255 related articles for article (PubMed ID: 8902784)

  • 1. Prevention of fetal death in the antiphospholipid antibody syndrome.
    Cowchock S
    Lupus; 1996 Oct; 5(5):467-72. PubMed ID: 8902784
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Treatment of antiphospholipid syndrome in pregnancy.
    Cowchock S
    Lupus; 1998; 7 Suppl 2():S95-7. PubMed ID: 9814682
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A multicenter, placebo-controlled pilot study of intravenous immune globulin treatment of antiphospholipid syndrome during pregnancy. The Pregnancy Loss Study Group.
    Branch DW; Peaceman AM; Druzin M; Silver RK; El-Sayed Y; Silver RM; Esplin MS; Spinnato J; Harger J
    Am J Obstet Gynecol; 2000 Jan; 182(1 Pt 1):122-7. PubMed ID: 10649166
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Repeated fetal losses associated with antiphospholipid antibodies: a collaborative randomized trial comparing prednisone with low-dose heparin treatment.
    Cowchock FS; Reece EA; Balaban D; Branch DW; Plouffe L
    Am J Obstet Gynecol; 1992 May; 166(5):1318-23. PubMed ID: 1595785
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Randomized study of subcutaneous low molecular weight heparin plus aspirin versus intravenous immunoglobulin in the treatment of recurrent fetal loss associated with antiphospholipid antibodies.
    Triolo G; Ferrante A; Ciccia F; Accardo-Palumbo A; Perino A; Castelli A; Giarratano A; Licata G
    Arthritis Rheum; 2003 Mar; 48(3):728-31. PubMed ID: 12632426
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Low-molecular-weight heparin versus intravenous immunoglobulin for recurrent abortion associated with antiphospholipid antibody syndrome.
    Dendrinos S; Sakkas E; Makrakis E
    Int J Gynaecol Obstet; 2009 Mar; 104(3):223-5. PubMed ID: 19116178
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Aspirin or heparin or both in the treatment of recurrent spontaneous abortion in women with antiphospholipid antibody syndrome: a meta-analysis of randomized controlled trials.
    Lu C; Liu Y; Jiang HL
    J Matern Fetal Neonatal Med; 2019 Apr; 32(8):1299-1311. PubMed ID: 29179589
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Does aspirin have a role in improving pregnancy outcome for women with the antiphospholipid syndrome? A randomized controlled trial.
    Pattison NS; Chamley LW; Birdsall M; Zanderigo AM; Liddell HS; McDougall J
    Am J Obstet Gynecol; 2000 Oct; 183(4):1008-12. PubMed ID: 11035355
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Therapeutic use of intravenous immunoglobulins in the antiphospholipid syndrome].
    Piette JC; Lê Thi Huong D; Wechsler B
    Ann Med Interne (Paris); 2000 May; 151 Suppl 1():1S51-4. PubMed ID: 10896991
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Treatment of pregnancy loss in Hughes syndrome: a critical update.
    Ruiz-Irastorza G; Khamashta MA; Hughes GR
    Autoimmun Rev; 2002 Oct; 1(5):298-304. PubMed ID: 12848984
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Randomised controlled trial of aspirin and aspirin plus heparin in pregnant women with recurrent miscarriage associated with phospholipid antibodies (or antiphospholipid antibodies).
    Rai R; Cohen H; Dave M; Regan L
    BMJ; 1997 Jan; 314(7076):253-7. PubMed ID: 9022487
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Therapeutic management of antiphospholipid antibody syndrome in pregnancy].
    Edelman P
    Contracept Fertil Sex; 1993 Nov; 21(11):817-20. PubMed ID: 8281230
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The HELLP syndrome in the antiphospholipid syndrome: retrospective study of 16 cases in 15 women.
    Le Thi Thuong D; Tieulié N; Costedoat N; Andreu MR; Wechsler B; Vauthier-Brouzes D; Aumaître O; Piette JC
    Ann Rheum Dis; 2005 Feb; 64(2):273-8. PubMed ID: 15647435
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Recurrent fetal death and antiphospholipid antibody syndrome. A case report].
    Rojas-Poceros G; Ramírez Peredo J; Hernández Andrade E; Bustos López HH
    Ginecol Obstet Mex; 1997 Dec; 65():523-8. PubMed ID: 9477648
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Outcome of treated pregnancies in women with antiphospholipid syndrome: an update of the Utah experience.
    Branch DW; Silver RM; Blackwell JL; Reading JC; Scott JR
    Obstet Gynecol; 1992 Oct; 80(4):614-20. PubMed ID: 1407882
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Treatment of recurrent spontaneous abortion associated with the antiphospholipid antibody syndrome].
    Carbonne B; Lejeune V
    Gynecol Obstet Fertil; 2003 Sep; 31(9):789-93. PubMed ID: 14499730
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Antiphospholipid syndrome in obstetrics.
    Heilmann L; von Tempelhoff GF; Pollow K
    Clin Appl Thromb Hemost; 2003 Apr; 9(2):143-50. PubMed ID: 12812384
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Upgrading Therapy Strategy Improves Pregnancy Outcome in Antiphospholipid Syndrome: A Cohort Management Study.
    Hoxha A; Favaro M; Calligaro A; Del Ross T; Ruffatti AT; Infantolino C; Tonello M; Mattia E; Ruffatti A
    Thromb Haemost; 2020 Jan; 120(1):36-43. PubMed ID: 31634958
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pregnancy outcome. Influence of antiphospholipid antibody titer, prior pregnancy losses and treatment.
    Reece EA; Garofalo J; Zheng XZ; Assimakopoulos E
    J Reprod Med; 1997 Jan; 42(1):49-55. PubMed ID: 9018646
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Successful pregnancy outcome with combination therapy in women with the antiphospholipid antibody syndrome.
    Menashe Y; Ben-Baruch G; Greenspoon JS; Carp HJ; Rosen DJ; Mashiach S; Many A
    J Reprod Med; 1993 Aug; 38(8):625-9. PubMed ID: 8410869
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.